Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients. | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Recruiting	Phase 2	2026-07-21		NCT07717268

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Fundacion Miguel Servet	23
Instituto de Investigación en Oncología Radioterápica - Fundación Española de Oncología Radioterápic	4

15 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Complexo Hospitalario Universitario De Santiago	Santiago de Compostela	Spain	1
Consorci Sanitari De Terrassa	Terrassa	Spain	4
Hospital Clinic de Barcelona	Barcelona	Spain	19
Hospital Clínico San Carlos	Madrid	Spain	29
Hospital Clínico Universitario de Valladolid	Valladolid	Spain	5
Hospital de Cruces	Barakaldo	Spain	9
Hospital de la Santa Creu i Sant Pau	Barcelona	Spain	20
Hospital Ramón y Cajal	Madrid	Spain	4
Hospital Universitario Basurto	Bilbao	Spain	2
Hospital Universitario Central de Asturias	Oviedo	Spain	57
Hospital Universitario de Navarra (HUN)	Pamplona	Spain	1
Hospital Universitario de Salamanca	Salamanca	Spain	9
Hospital Universitario Miguel Servet	Zaragoza	Spain	7
Hospital Universitario y Politécnico de La Fe	Valencia	Spain	2
Instituto Catalán de Oncología Hospitalet	L'Hospitalet de Llobregat	Spain	2